CA
TNDM icon

Cetera Advisors’s Tandem Diabetes Care TNDM Stock Holding History

Cetera Advisors’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,586
Closed -$301K – 1474
2022
Q1 		$301K Buy
+2,586
New +$302K 0.01% 1107
2021
Q1 		– Sell
-6,066
Closed -$580K – 1245
2020
Q4 		$580K Buy
6,066
+1,313
+28% +$135K 0.02% 582
2020
Q3 		$539K Sell
4,753
-2,332
-33% -$245K 0.02% 528
2020
Q2 		$701K Sell
7,085
-97
-1% -$7.74K 0.03% 447
2020
Q1 		$462K Buy
7,182
+49
+0.7% +$3.43K 0.02% 492
2019
Q4 		$425K Sell
7,133
-2,630
-27% -$162K 0.02% 610
2019
Q3 		$579K Sell
9,763
-3,150
-24% -$201K 0.03% 498
2019
Q2 		$832K Buy
12,913
+5,315
+70% +$343K 0.04% 421
2019
Q1 		$485K Buy
+7,598
New +$399K 0.02% 505

Other funds holding TNDM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Cetera Advisors's TNDM Position: Q2 2022 in Review

Cetera Advisors sold out of Tandem Diabetes Care (TNDM) in Q2 2022, closing a stake of 2,586 shares — an estimated $301K sold.

Cetera Advisors first reported a position in TNDM in Q1 2019 and held it in 9 quarters. The position peaked at $832K in Q2 2019. 330 funds tracked by Wall St. Rank hold TNDM as of Q2 2022.

  • Cetera Advisors reported no remaining Tandem Diabetes Care position as of Q2 2022 after selling out during the quarter.
  • Cetera Advisors sold 2,586 Tandem Diabetes Care shares in Q2 2022, an estimated $301K.
  • Cetera Advisors first reported a position in Tandem Diabetes Care in Q1 2019 and held it in 9 quarters.
  • Cetera Advisors's Tandem Diabetes Care position peaked at $832K in Q2 2019.
  • 330 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2022.

Based on Cetera Advisors's 13F filing for Q2 2022, filed 11 Aug 2022.